Andrew Rosenberg, DVM, DACVD, provided an overview of Janus kinase inhibitors for treating canine atopic dermatitis ...

When the session moderator asked whether the findings meant cardiovascular risk was no longer a worry with JAK inhibitors ...

Patients with IBD don’t face an increased risk for major adverse cardiovascular events when taking Janus kinase inhibitors ...

The landscape of atopic dermatitis (AD) treatment is advancing with approvals of oral and topical Janus kinase (JAK) ...

New and in-the-pipeline Janus kinase (JAK) inhibitors have the potential to make huge differences in the lives of patients ...

The following is a summary of “Comparative safety of oral Janus kinase inhibitors versus dupilumab in patients with atopic ...

So it's a good question. And, you know, there's now 2 JAK inhibitors in veterinary medicine on the market. The first, of course, was Apoquel, and that was a Jak inhibitor. And now there's a new drug ...

Most patients with rheumatoid arthritis or spondyloarthritis had significant antibody responses to COVID vaccine boosters, whether or not their immunomodulatory medications were held.

InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, today ann ...